Alps Advisors Inc Rapt Therapeutics, Inc. Transaction History

Alps Advisors Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$6.87 - $26.45 $7,172 - $27,613	1,044 Added 4.5%	24,259 $217,000
Q4 2023 Feb 14, 2024	SELL	$11.28 - $25.46 $24,240 - $54,713	-2,149 Reduced 8.47%	23,215 $576,000
Q3 2023 Nov 14, 2023	BUY	$16.34 - $24.66 $1,911 - $2,885	117 Added 0.46%	25,364 $421,000
Q2 2023 Aug 14, 2023	BUY	$16.06 - $21.61 $46,317 - $62,323	2,884 Added 12.9%	25,247 $472,000
Q1 2023 May 10, 2023	SELL	$17.19 - $30.8 $11,121 - $19,927	-647 Reduced 2.81%	22,363 $410,000
Q4 2022 Feb 14, 2023	BUY	$16.28 - $24.6 $111,143 - $167,944	6,827 Added 42.19%	23,010 $455,000
Q3 2022 Nov 14, 2022	SELL	$17.96 - $30.46 $25,251 - $42,826	-1,406 Reduced 7.99%	16,183 $389,000
Q2 2022 Aug 11, 2022	SELL	$10.26 - $23.59 $131,389 - $302,093	-12,806 Reduced 42.13%	17,589 $321,000
Q1 2022 May 16, 2022	SELL	$17.02 - $40.22 $64,573 - $152,594	-3,794 Reduced 11.1%	30,395 $668,000
Q4 2021 Feb 09, 2022	SELL	$29.5 - $39.5 $57,525 - $77,025	-1,950 Reduced 5.4%	34,189 $1.26 Million
Q3 2021 Nov 15, 2021	BUY	$29.86 - $39.47 $95,731 - $126,540	3,206 Added 9.73%	36,139 $1.12 Million
Q2 2021 Aug 11, 2021	BUY	$17.99 - $40.02 $592,464 - $1.32 Million	32,933 New	32,933 $1.05 Million

104

27.1M

26.7K

2.4K

Ticker RAPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,656,600
Market Cap $26.1M
Description
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.